Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional Results available

A Research Study in Children Born Small and Who Stayed Small. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day

ClinicalTrials.gov ID: NCT03878446

Public ClinicalTrials.gov record NCT03878446. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 14, 2026, 7:21 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Dose-finding Trial Evaluating the Effect and Safety of Once-weekly Treatment of Somapacitan Compared to Daily Norditropin® in Children With Short Stature Born Small for Gestational Age With no Catch-up Growth by 2 Years of Age or Older

Study identification

NCT ID
NCT03878446
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
62 participants

Conditions and interventions

Interventions

  • Norditropin® Drug
  • Somapacitan Drug

Drug

Eligibility (public fields only)

Age range
2 Years to 11 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 3, 2019
Primary completion
May 4, 2021
Completion
Dec 22, 2026
Last update posted
Dec 22, 2025

2019 – 2026

United States locations

U.S. sites
14
U.S. states
10
U.S. cities
14
Facility City State ZIP Site status
Univ of AL at Birmingham_BRM Birmingham Alabama 35233
Children's Hosp Of Orange Orange California 92868
St. Luke's Children's Endo Boise Idaho 83712
Univ of Minnesota M.C.H. Minneapolis Minnesota 55454
Children's Minnesota Saint Paul Minnesota 55102
Goryeb Children's Hospital Morristown New Jersey 07962
Rutgers-Rwjms New Brunswick New Jersey 08901
NYU Langone Hospital-LI Garden City New York 11530
NYU Langone Hospital-LI Mineola New York 11501
Icahn Sch of Med-Mt Sinai Hosp New York New York 10029
CCHMC_Cinc Cincinnati Ohio 45229
Univ Oklahoma Sci Ctr OK City Oklahoma City Oklahoma 73104
Cook Children's Hospital-Hematology-Oncology Fort Worth Texas 76104
MultiCare Inst for Res & Innov Tacoma Washington 98405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 78 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03878446, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 22, 2025 · Synced May 14, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03878446 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →